Skip to content

KZIA

Kazia Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$10.39
−4.33%
Ask drillr

Leverage

Debt / equity
0.00x
Net debt / equity
-1.49x
Debt / assets
0.00x
Debt / EBITDA
-0.01x
Net debt / EBITDA
3.82x

Liquidity & coverage

Current ratio
2.87x
Quick ratio
2.87x
Cash ratio
2.85x
Interest coverage
EBITDA / interest
Working capital
$32.4M

Cash & dividend

FCF / debt
-91.93x
Cash flow / debt
-133.90x
Dividend per share
Dividend yield
Dividend growth 1y

Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025